scholarly journals The value of molecular stratification forCEBPADMandNPM1MUTFLT3WTgenotypes in older patients with acute myeloid leukaemia

2015 ◽  
Vol 172 (4) ◽  
pp. 573-580 ◽  
Author(s):  
Glenda J. Dickson ◽  
Sophia Bustraan ◽  
Robert K. Hills ◽  
Akbar Ali ◽  
Anthony H. Goldstone ◽  
...  
Keyword(s):  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Older Patients ◽  
Molecular Stratification ◽  
Acute Myeloid

Allo-HCT regimens with low toxicity needed in older patients with acute myeloid leukaemia

2016 ◽  
Vol 17 (1) ◽  
pp. e1
Author(s):  
Mohamed A Kharfan-Dabaja ◽  
Taiga Nishihori ◽  
Ali Bazarbachi
Keyword(s):  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Older Patients ◽  
Low Toxicity ◽  
Acute Myeloid

Outcomes of non‐myeloablative allogeneic stem cell transplant in older patients with acute myeloid leukaemia in first remission

2021 ◽  
Vol 51 (11) ◽  
pp. 1954-1958
Author(s):  
Phillip C. Nguyen ◽  
Kate Manos ◽  
Chun Y. Fong ◽  
Anthony P. Schwarer ◽  
Ing S. Tiong ◽  
...  
Keyword(s):  
Stem Cell ◽  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Older Patients ◽  
Stem Cell Transplant ◽  
Cell Transplant ◽  
Allogeneic Stem Cell Transplant ◽  
First Remission ◽  
Acute Myeloid

A randomised comparison of the novel nucleoside analogue sapacitabine with low-dose cytarabine in older patients with acute myeloid leukaemia

Leukemia ◽  
2015 ◽  
Vol 29 (6) ◽  
pp. 1312-1319 ◽  
Author(s):  
A K Burnett ◽  
N Russell ◽  
R K Hills ◽  
N Panoskaltsis ◽  
A Khwaja ◽  
...  
Keyword(s):  
Acute Myeloid Leukaemia ◽  
Myeloid Leukaemia ◽  
Nucleoside Analogue ◽  
Older Patients ◽  
Low Dose ◽  
The Novel ◽  
Low Dose Cytarabine ◽  
Acute Myeloid
Sign in / Sign up

Export Citation Format

Share Document